1. Home
  2. STXS vs BPOPM Comparison

STXS vs BPOPM Comparison

Compare STXS & BPOPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • BPOPM
  • Stock Information
  • Founded
  • STXS 1990
  • BPOPM N/A
  • Country
  • STXS United States
  • BPOPM United States
  • Employees
  • STXS N/A
  • BPOPM N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BPOPM Major Banks
  • Sector
  • STXS Health Care
  • BPOPM Finance
  • Exchange
  • STXS Nasdaq
  • BPOPM Nasdaq
  • Market Cap
  • STXS 151.3M
  • BPOPM N/A
  • IPO Year
  • STXS 2004
  • BPOPM N/A
  • Fundamental
  • Price
  • STXS $2.18
  • BPOPM $25.65
  • Analyst Decision
  • STXS
  • BPOPM
  • Analyst Count
  • STXS 0
  • BPOPM 0
  • Target Price
  • STXS N/A
  • BPOPM N/A
  • AVG Volume (30 Days)
  • STXS 285.8K
  • BPOPM N/A
  • Earning Date
  • STXS 05-12-2025
  • BPOPM N/A
  • Dividend Yield
  • STXS N/A
  • BPOPM N/A
  • EPS Growth
  • STXS N/A
  • BPOPM N/A
  • EPS
  • STXS N/A
  • BPOPM N/A
  • Revenue
  • STXS $26,918,000.00
  • BPOPM N/A
  • Revenue This Year
  • STXS $25.90
  • BPOPM N/A
  • Revenue Next Year
  • STXS $60.57
  • BPOPM N/A
  • P/E Ratio
  • STXS N/A
  • BPOPM N/A
  • Revenue Growth
  • STXS 0.55
  • BPOPM N/A
  • 52 Week Low
  • STXS $1.54
  • BPOPM N/A
  • 52 Week High
  • STXS $2.72
  • BPOPM N/A
  • Technical
  • Relative Strength Index (RSI)
  • STXS 66.61
  • BPOPM 54.61
  • Support Level
  • STXS $1.93
  • BPOPM $25.59
  • Resistance Level
  • STXS $2.07
  • BPOPM $25.96
  • Average True Range (ATR)
  • STXS 0.09
  • BPOPM 0.12
  • MACD
  • STXS 0.03
  • BPOPM 0.00
  • Stochastic Oscillator
  • STXS 94.05
  • BPOPM 32.65

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: